← All stocks

uniQure N.V.

QURE Net selling
CIK 0001590560 #1650 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$32.40M
$73.77K on a plan · $30.07M straight out of an exercise
Sold at will
$2.26M
19 of 64 sales
Net
−$32.40M
−$2.26M against sales at will

By person

12 insiders · 64 transactions
35.2×

Matthew Kapusta holds 35.2 times base salary in stock. $23.83M of shares against $676.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Kapusta last reported holding, valued at $45.89, the price Ordinary Shares was last bought or sold at on the open market here, on 2 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kapusta Matthew C
CEO, Managing Director
$22.25M (21) scheduled
−$22.25M
519,227
0.7485%
$23.83M
−12.1%
Kaye Jack
Director
$2.69M (9) scheduled
−$2.69M
25,996
0.0375%
$1.19M
+78.3%
Abi-Saab Walid
Chief Medical Officer
$2.61M (7) scheduled
−$2.61M
148,235
0.2137%
$6.80M
+28.6%
Gut Robert
Director
$1.76M (9) scheduled
−$1.76M
32,259
0.0465%
$1.48M
−36.9%
KLEMT CHRISTIAN
Chief Financial Officer
$1.33M (5) scheduled
−$1.33M
226,581
0.3266%
$10.40M
+37.5%
Balachandran Madhavan
Director
$858.92K (5) scheduled
−$858.92K
43,254
0.0624%
$1.98M
+35.9%
O'Keefe Kylie
Chief Customer & Strat Officer
$431.23K (1)
−$431.23K
108,864
0.1569%
$5.00M
+3.7%
Potts Jeannette
Chief Legal Officer
$261.17K (3)
−$261.17K
133,246
0.1921%
$6.11M
+45.1%
Jacques Rachelle Suzanne
Director
$53.93K (1)
−$53.93K
33,903
0.0489%
$1.56M
+50.8%
Meek David D.
Director
$53.93K (1)
−$53.93K
39,747
0.0573%
$1.82M
+40.3%
POST LEONARD E
Director
$53.93K (1)
−$53.93K
35,494
0.0512%
$1.63M
+47.4%
Springhorn Jeremy P.
Director
$53.93K (1)
−$53.93K
43,251
0.0624%
$1.98M
+35.9%
Insider
Date
Role
Action
Shares
Price
Amount
Abi-Saab Walid
26 Jun 2026
Chief Medical Officer
Sell
1,434
$46.86
$67.20K
Potts Jeannette
15 Jun 2026
Chief Legal Officer
Sell
5,237
$27.67
$144.91K
Balachandran Madhavan
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Jacques Rachelle Suzanne
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Kaye Jack
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
POST LEONARD E
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Springhorn Jeremy P.
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
O'Keefe Kylie
11 Jun 2026
Chief Customer & Strat Officer
Sell
15,936
$27.06
$431.23K
Meek David D.
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
KLEMT CHRISTIAN
4 Mar 2026
Chief Financial Officer
Sell
12,000
$9.06
$108.72K
Potts Jeannette
4 Mar 2026
Chief Legal Officer
Sell
3,412
$9.06
$30.91K
Abi-Saab Walid
4 Mar 2026
Chief Medical Officer
Sell
808
$9.06
$7.32K
Kapusta Matthew C
4 Mar 2026
CEO, Managing Director
Sell
14,581
$9.06
$132.10K
Abi-Saab Walid
2 Mar 2026
Chief Medical Officer
Sell
1,660
$9.95
$16.52K
Potts Jeannette
2 Mar 2026
Chief Legal Officer
Sell
8,578
$9.95
$85.35K
KLEMT CHRISTIAN
2 Mar 2026
Chief Financial Officer
Sell
12,532
$9.95
$124.69K
Kapusta Matthew C
2 Mar 2026
CEO, Managing Director
Sell
34,437
$9.95
$342.65K
KLEMT CHRISTIAN
25 Feb 2026
Chief Financial Officer
Sell
6,217
$23.86
$148.34K
Kapusta Matthew C
25 Feb 2026
CEO, Managing Director
Sell
12,378
$23.86
$295.34K

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 44
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 792,716
History held since 31 Jan 2017